Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–323.
Galson SW, Stanifer JW, Hertz JT, Temu G, Thielman N, Gafaar T, et al. The burden of hypertension in the emergency department and linkage to care: A prospective cohort study in Tanzania. PloS One. 2019;14:e0211287.
CAS PubMed PubMed Central Google Scholar
Mosha NR, Mahande M, Juma A, Mboya I, Peck R, Urassa M, et al. Prevalence,awareness and factors associated with hypertension in North West Tanzania. Glob Health Action 2017;10:1321279.
PubMed PubMed Central Google Scholar
Mobula LM, Fisher ML, Lau N, Estelle A, Wood T, Plyler W. Prevalence of hypertension among patients attending mobile medical clinics in the Philippines after Typhoon Haiyan. PLoS Curr. 2016;8:ecurrents.dis.5aaeb105e840c72370e8e688835882ce.
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255–64.
Astarita A, Covella M, Vallelonga F, Cesareo M, Totaro S, Ventre L, et al. Hypertensive emergencies and urgencies in emergency departments: a systematic review and meta-analysis. J Hypertens. 2020;38:1203–10.
NICE. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. August 2019. https://www.nice.org.uk/guidance/NG136. Accessed 15 May 2022
Heath I. Hypertensive urgency—is this a useful diagnosis? JAMA Intern Med. 2016;176:988–9.
Patel KK, Young L, Howell EH, Hu B, Rutecki G, Thomas G, et al. Characteristics and outcomes of patients presenting with hypertensive urgency in the office setting. JAMA Intern Med. 2016;176:981–8.
Sharp PS, Chaturvedi N, Wormald R, McKeigue PM, Marmot MG, Young SM. Hypertensive retinopathy in Afro-Caribbeans and Europeans. Hypertension. 1995;25:1322–5.
Dodson PM, Lip GY, Eames SM, Gibson JM, Beevers DG. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens. 1996;10:93–8.
Lip GY, Beevers M, Dodson PM, Beevers DG. Severe hypertension with lone bilateral papilloedema: a variant of malignant hypertension. Blood Press. 1995;4:339–42.
Domek M, Gumprecht J, Lip GYH, Shantsila A. Malignant hypertension: does this still exist? J Hum Hypertens. 2020;34:1–4.
Shah BM, Sadaka A, Berry S, Malik A, Lee AG. Bilateral disc edema in hypertensive emergency. Can J Ophthalmol J Can d’ophtalmol. 2018;53:e113–e5.
Cremer A, Amraoui F, Lip GY, Morales E, Rubin S, Segura J, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens. 2016;30:463–6.
Katz JN, Gore JM, Amin A, Anderson FA, Dasta JF, Ferguson JJ, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J.2009;158:599–606.e1
Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Preval Clin Present Hypertens. 1996;27:144–7.
Alshami A, Romero C, Avila A, Varon J. Management of hypertensive crises in the elderly. J Geriatr Cardiol. 2018;15:504–12.
CAS PubMed PubMed Central Google Scholar
Shantsila A, Shantsila E, Beevers DG, Lip GYH. Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. J Hypertens. 2017;35:2310–4.
Shin JH, Kim BS, Lyu M, Kim HJ, Lee JH, Park, JK et al. Clinical characteristics and predictors of all-cause mortality in patients with hypertensive urgency at an emergency department. J Clin Med. 2021;10:4314.
Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1974;268:336–45.
Lane DA, Lip GYH, Beevers DG. Improving survival of malignant hypertension patients over 40 years. Am J Hypertens 2009;22:1199–204.
Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995;13:915–24.
Spence JD, Rayner BL. Hypertension in blacks: individualized therapy based on renin/aldosterone phenotyping. Hypertension. 2018;72:263–9.
Waldron FA, Benenson I, Jones-Dillon SA, Zinzuwadia SN, Adeboye AM, Eris E, et al. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community. Blood Press. 2019;28:114–23.
Lane DA, Lip GY. Ethnic differences in hypertension and blood pressure control in the UK. QJM. 2001;94:391–6.
DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.
Fragoulis C, Dimitriadis K, Siafi E, Iliakis P, Kasiakogias A, Kalos T, et al. Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry. Eur J Prev Cardiol. 2022;29:194–201.
Kettani FZ, Dragomir A, Côté R, Roy L, Bérard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009;40:213–20.
Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990;263:1653–7.
Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161–92. Summer
Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br Med J. 1973;1:507–10.
CAS PubMed PubMed Central Google Scholar
Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976;53:720–7.
Immink RV, van den Born B-JH, van Montfrans GA, Koopmans RP, Karemaker JM, van Lieshout JJ. Impaired cerebral autoregulation in patients with malignant hypertension. Circulation. 2004;110:2241–5.
Ledingham JG. Management of hypertensive crises. Hypertension. 1983;5:III114–9.
Haas DC, Streeten DHP, Kim RC, Naalbandian AN, Obeid AI. Death from cerebral hypoperfusion during nitroprusside treatment of acute angiotensin-dependent hypertension. Am J Med. 1983;75:1071–6.
Burton TJ, Wilkinson IB. The dangers of immediate-release nifedipine in the emergency treatment of hypertension. J Hum Hypertens 2008;22:301–2.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e426–e83.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.
van den Born BH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37–46.
Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol. 1998;9:133–42.
Rubin S, Cremer A, Boulestreau R, Rigothier C, Kuntz S, Gosse P. Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort. J Hypertens. 2019;37:316–24.
Watson K, Broscious R, Devabhakthuni S, Noel ZR. Focused update on pharmacologic management of hypertensive emergencies. Curr Hypertens Rep. 2018;20:56.
Ulici A, Jancik J, Lam TS, Reidt S, Calcaterra D, Cole JB. Clevidipine versus sodium nitroprusside in acute aortic dissection: a retrospective chart review. Am J Emerg Med. 2017;35:1514–8.
Hirschl MM, Binder M, Bur A, Herkner H, Mullner M, Woisetschlager C, et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Med. 1997;23:885–8.
Hirschl MM, Seidler D, Zeiner A, Wagner A, Heinz G, Sterz F, et al. Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies. Am J Emerg Med. 1993;11:653–6.
Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 1993;95:161–8.
NICE. Acute kidney injury: prevention, detection and management National Institute for Health and Care Excellence; 2019 [https://www.nice.org.uk/guidance/ng148} Accessed 15 May 2022.
NICE. Chronic Kidney Disease: assessment and management (NG203): National Institute for Health and Care Excellence; 2021 [https://www.nice.org.uk/guidance/ng203] Accessed on 15 May 2022
Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99:559–69.
留言 (0)